Home | Welcome to Contract Pharma   
Last Updated Wednesday, May 22 2013
Print

Collaborations & Alliances

Related Searches:

Filter by:

June 29, 2011
Proteros to add protein crystallization, X-ray structural analysis to AMRI discovery offerings   Read More »
June 29, 2011
Will supply methadone to Ascend   Read More »
June 28, 2011
Joint venture aims to rapidly identify small molecule therapeutics to pharma targets   Read More »
June 28, 2011
Three-year deal will focus on neuroscience candidates   Read More »
June 27, 2011
Discover collaboration began in April 2009 for molecules targeting CV, CNS, urology   Read More »
June 24, 2011
RCB to use maxXpress to help develop fusion protein for autoimmune indications   Read More »
June 24, 2011
Three-year deal covers development-stage cancer drugs, may lead to companion diagnostics   Read More »
June 23, 2011
Jubilant Biosys Ltd., a subsidiary of Jubilant Life Sciences Ltd., has successfully completed an early stage milestone in its neuroscience collaboration with AstraZeneca in the pain therapeutic area.   Read More »
June 21, 2011
Once-weekly diabetes injection cleared in EU   Read More »
June 21, 2011
Porsolt and JSW sign a strategic collaboration agreement to co-market contract research services.   Read More »
June 21, 2011
Will undertake formulation development and clinical testing for RhuDex RA treatment   Read More »
June 20, 2011
Sales team to support PHN treatment Gralise   Read More »
June 20, 2011
Deal covers clinical and commercial supplies for patented cyclodextrin   Read More »
June 20, 2011
Development candidate to advance in oncology   Read More »
June 20, 2011
Anti-IL-6 MAb goes into Phase IIb   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On